IMAGE-AF: Willingness to accept brain imaging evaluation for the optimisation of anticoagulation management among people with atrial fibrillation and low-to-intermediate stroke risk
Who it’s for: Health professionals
What it involves: Survey, focus group
Location: Online (Australia)
Summary
Researchers from The George Institute for Global Health invite clinicians to take part in this study exploring how brain imaging could support anticoagulation decisions.
Silent brain infarction (SBI) – a past, asymptomatic stroke only detectable via brain imaging – affects 1 in 3 people with atrial fibrillation (AF) and is linked to a 2-fold increase in future stroke risk. Despite its potential, brain imaging is not routinely used in this population, and little is known about clinician views on its feasibility, utility, and barriers to implementation.
This study seeks input from clinicians on:
- Current anticoagulation practices
- Knowledge and awareness of silent brain infarction (SBI)
- Attitudes toward imaging-guided stroke prevention.
Eligibility
- Registered clinicians in Australia involved in anticoagulation decisions/prescription for people with non-valvular atrial fibrillation (AF) who have not experienced a stroke. (Non-valvular AF refers to AF in the absence of moderate-to-severe heart valve disorder or a mechanical heart valve.)
Activity
- An online survey – participants can choose to complete a short version that may take 5–7 minutes, or a full version that may take 8–13 minutes to complete.
- To express your interest in participating, please sign up for the survey online.
Documents
Contact
For more information, contact the research team at imageaf@georgeinstitute.org.au